Stichting European Myeloma Network
Clinical trials sponsored by Stichting European Myeloma Network, explained in plain language.
-
CAR-T therapy challenges standard transplant in major myeloma trial
Disease control OngoingThis large study aims to see if a newer personalized cell therapy (CAR-T) works better than the current standard stem cell transplant for controlling multiple myeloma. It will involve about 759 adults newly diagnosed with this blood cancer who are eligible for intensive treatment…
Phase: PHASE3 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Four-Drug attack on blood cancer shows promise in major trial
Disease control OngoingThis study is testing whether adding a drug called daratumumab to a standard three-drug combination works better for people newly diagnosed with multiple myeloma, a cancer of plasma cells in the bone marrow. It will involve about 709 participants who are eligible for a stem cell …
Phase: PHASE3 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC